Global
Biomarkers
Market is expected to grow at a significant CAGR in the forthcoming
years. Biomarkers enable a powerful and dynamic approach to determine the
spectrum of neurological disease with applications in analytic and
observational epidemiology, randomized clinical trials, prognosis, diagnosis
and screening. Study about biomarkers reveal the alterations in components of
body fluids and tissues, and also offers the platform for homogeneous taxonomy
of a disease. Biomarkers, again can exhibit the stages of disease ranging from
to early manifestations to later stages.
View Full Report with TOC @ https://www.millioninsights.com/industry-reports/biomarkers-market
Driving
factors responsible for the growth of biomarkers market include rise in
diagnostic applications of biomarkers, increase in R&D funding for biotech
and pharma companies, rise in number of CROs and reasonable cost for clinical
trials in emerging economies. Also, the rising cases of cancer and initiatives
for research and development add to the market growth. However, the high
capital investments and low proportion of cost-benefit coupled with minimal
government regulations and reimbursement systems and more probably the
technical issues pertaining to collection and storage are the major restraining
factors responsible for the market.
 |
| Biomarker Market |
Based
on segmentation by product, the biomarker market includes services, software
and consumables. Based on segmentation by type, the biomarkers market includes
safety biomarkers, efficacy biomarkers, predictive biomarkers, surrogate
biomarkers, pharmacodynamics biomarkers, prognostic biomarkers and validation
biomarkers.
Based
on segmentation by application, biomarker market includes diagnostics
development, drug discovery and development, personalized medicine, DNA
fingerprinting, ecotoxicology, forensics and disease risk assessment. Based on
segmentation by indication, the biomarkers market includes cancer,
cardiovascular disorders, neurological disorders, immunological disorders,
renal disorders, urinal diseases and tuberculosis.
Geographically,
biomarker market spans North America, Latin America, Europe, Asia-Pacific,
Middle-East and Africa. North America dominates the global market owing to rise
in R&D spending for biomarker R&D and growth in technological
infrastructure are some growth factors for market growth in North America. APAC
market is also expected to gain a positive CAGR growth in the forthcoming
period owing to rise in use of biomarkers for diagnostic purpose, rise in
incidences of chronic disease and rise in outsourcing of pharmaceutical R&D
activities.The key players in the biomarkers market include QIAGEN N.V.,
PerkinElmer Inc, Merck Millipore, Bio-Rad Laboratories Inc and Enzo Biochem
Inc.
Market Segment:
This report focuses on the global top
players, covered
•
QIAGEN N.V. (Netherlands)
•
PerkinElmer, Inc. (U.S.)
•
Merck Millipore (U.S.)
•
Bio-Rad Laboratories, Inc. (U.S.)
•
Enzo Biochem, Inc. (U.S.)
Market segment by Regions/Countries,
this report covers
•
United States
•
Europe
•
China
•
Japan
•
Southeast Asia
•
India
Market segment by Type, the product can
be split into
•
Consumables
•
Service
Market segment by Application, split
into
•
Diagnostics Development
•
Drug Discovery and Development
•
Disease-Risk
Request a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/biomarkers-market/request-sample
No comments:
Post a Comment